These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1715740)

  • 1. Overview of FK506 in transplantation.
    Fung JJ; Abu-Elmagd K; Todo S; Shapiro R; Tzakis A; Jordan M; Armitage J; Jain A; Alessiani M; Martin M
    Clin Transpl; 1990; ():115-21. PubMed ID: 1715740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients.
    McKee M; Segev D; Wise B; Case B; Neu A; Fivush B; Colombani P
    J Pediatr Surg; 1997 May; 32(5):688-90. PubMed ID: 9165452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus.
    Cao S; Cox KL; Berquist W; Hayashi M; Concepcion W; Hammes GB; Ojogho OK; So SK; Frerker M; Castillo RO; Monge H; Esquivel CO
    Pediatr Transplant; 1999 Feb; 3(1):22-6. PubMed ID: 10359027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial.
    McDiarmid SV; Busuttil RW; Ascher NL; Burdick J; D'Alessandro AM; Esquivel C; Kalayoglu M; Klein AS; Marsh JW; Miller CM
    Transplantation; 1995 Feb; 59(4):530-6. PubMed ID: 7533345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective randomized trial comparing the efficacy of tacrolimus versus cyclosporine in black recipients of primary cadaveric renal transplants.
    Raofi V; Holman DM; Coady N; Vazquez E; Dunn TB; Bartholomew AM; Pollak R; Benedetti E
    Am J Surg; 1999 Apr; 177(4):299-302. PubMed ID: 10326847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
    Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
    J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation.
    Kershner RP; Fitzsimmons WE
    Transplantation; 1996 Oct; 62(7):920-6. PubMed ID: 8878385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notes on FK 506.
    Starzl TE; Fung J; Todo S; Tzakis A
    Transplant Proc; 1991 Aug; 23(4):2178-9. PubMed ID: 1714647
    [No Abstract]   [Full Text] [Related]  

  • 11. Tacrolimus: a further update of its use in the management of organ transplantation.
    Scott LJ; McKeage K; Keam SJ; Plosker GL
    Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of intractable rejection with tacrolimus (FK506) in pediatric liver transplant recipients.
    McDiarmid SV; Wallace P; Vargas J; Ament ME; Busuttil RW
    J Pediatr Gastroenterol Nutr; 1995 Apr; 20(3):291-9. PubMed ID: 7541834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different immunosuppressive effects of liposomal FK506 in liver and kidney transplantation.
    Ko S; Nakajima Y; Kanehiro H; Horikawa M; Yoshimura A; Kido K; Taki J; Aomatsu Y; Kin T; Yagura K; Ohyama T; Ohashi K; Yamada T; Nakano H
    Transplant Proc; 1996 Apr; 28(2):1066-8. PubMed ID: 8623229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.
    Neuhaus P; Blumhardt G; Bechstein WO; Platz KP; Jonas S; Mueller AR; Langrehr JM; Lohmann R; Schattenfroh N; Knoop M
    Transplantation; 1995 Jan; 59(1):31-40. PubMed ID: 7530868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy?
    Franz M; Regele H; Schmaldienst S; Stummvoll HK; Hörl WH; Pohanka E
    Transplantation; 1998 Nov; 66(9):1258-62. PubMed ID: 9825827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of the Sandoz radioimmunoassays for cyclosporine.
    Holt DW; Marsden JT; Fashola TO; Johnston A
    Transplant Proc; 1990 Jun; 22(3):1155-9. PubMed ID: 2349678
    [No Abstract]   [Full Text] [Related]  

  • 17. Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation.
    Platz KP; Mueller AR; Jonas S; Blumhardt G; Bechstein WO; Lobeck H; Neuhaus HL
    Clin Transplant; 1995 Jun; 9(3 Pt 1):146-54. PubMed ID: 7549052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine.
    Taler SJ; Textor SC; Canzanello VJ; Schwartz L; Porayko M; Wiesner RH; Krom RA
    Transplantation; 1996 Dec; 62(11):1588-92. PubMed ID: 8970613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of tacrolimus in postoperative treatment of patients with renal transplantation for diabetic end-stage renal disease].
    Yu LX; Shan HT; Fu SJ; Du CF; Ma JJ; Xu J; Deng WF; Wang YB
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1146-8. PubMed ID: 14625173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weaning of immunosuppression in liver transplant recipients.
    Mazariegos GV; Reyes J; Marino IR; Demetris AJ; Flynn B; Irish W; McMichael J; Fung JJ; Starzl TE
    Transplantation; 1997 Jan; 63(2):243-9. PubMed ID: 9020325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.